"The voice of oncology in Massachusetts."

Upcoming Events

MSCO events

- msco annual meeting - 



Friday, November 17, 2023

5:30-8:30 PM


Boston Marriott Newton

2345 Commonwealth Ave

Newton, MA 02466

Register Now

Join your oncology colleagues and expert faculty for the MSCO 2023 Annual Meeting that will be held at the Boston Marriott Newton on Friday, November 17, 2023. 

By attending our annual meeting, you can earn CME credit, as well as interact with faculty in Q&A designed to answer your more pressing questions.

All are welcome to attend - physicians, nurses, support staff, researchers, social workers, and previous award recipients. 

Food, Drinks and NetWorking

Why Attend?

  • Conveniently located just outside downtown Boston
  • Discover new products and services for your practice in the Exhibit Hall
  • Interact with award winners, experts and faculty
  • Network with local colleagues
  • Free registration - Thanks to the generous support of our corporate members

Keynote Speaker

Nancy U. Lin, MD

Associate Chief, Division of Breast Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA

Director, Metastatic Breast Cancer Program, DFCI

Director, Program for Patients with Breast Cancer Brain Metastases, DFCI

Medical Director, Breast Oncology Center Translational Hub, DFCI

Associate Professor of Medicine, Harvard Medical School

Dr. Lin is a medical oncologist and clinical investigator specializing in the care of patients with breast cancer. She received her medical degree from Harvard Medical School and trained in internal medicine at Brigham & Women’s Hospital prior to completion of fellowships in medical oncology and hematology at Dana-Farber/Mass General Brigham. Dr. Lin is an internationally recognized leader in the field of breast cancer brain metastases. She has led studies resulting in new treatment options for patients living with brain metastases (lapatinib, neratinib, tucatinib, high-dose trastuzumab, trastuzumab deruxtecan) and collaborates with laboratory-based investigators to bring the most promising regimens into clinical trials. Dr. Lin is the founder and director of the EMBRACE (Ending Metastatic Breast Cancer for Everyone) metastatic breast cancer program at Dana-Farber, which encompasses a comprehensive clinical program including personalized matching for clinical services and clinical trials, patient education, and coordination or care with community-based oncologists. The accompanying EMBRACE metastatic breast cancer research program is designed to catalyze clinical and translational research focused on advanced breast cancer, with projects ranging from quality of care, health care disparities, treatment resistance, and biomarker development.

Massachusetts Society of Clinical Oncologists ©2023

860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329  |  email: msco@mms.org

Powered by Wild Apricot Membership Software